758719-40-3

Upstream product

• 326598-95-2 (1R,3S,4S,5R)-5-acetoxy-3-hydroxy-4-methyl-1-(methoxycarbonyl)cyclohexane 
• 326622-28-0 (4R,6R)-6-acetoxy-1-methyl-4-(methoxycarbonyl)cyclohexene 
• 757240-15-6 (1R,5R)-5-Hydroxy-4-methyl-cyclohex-3-enecarboxylic acid methyl ester 
• 758719-38-9 methyl (1R,5R)-5-(tert-butyldiphenylsilyloxy)-4-methyl-3-cyclohexene-1-carboxylate 

Downstream Products

• 758719-42-5 (1S,3R,4R,5R)-3-(tert-Butyl-diphenyl-silanyloxy)-5-methanesulfonyloxy-4-methyl-cyclohexanecarboxylic acid methyl ester 
• 758719-43-6 methyl (1S,3R,4S,5S)-3-(tert-butyldiphenylsilyloxy)-4-methylbicyclo[3.1.0]hexane-1-carboxylate 
• 758719-79-8 [(1S,3R,4S,5S)-3-(tert-Butyl-diphenyl-silanyloxy)-4-methyl-bicyclo[3.1.0]hex-1-yl]-methanol 
• 758719-44-7 (1S,3R,4S,5S)-3-(tert-butyldiphenylsilyloxy)-4-methylbicyclo[3.1.0]hexane-1-carboxylate 

Relevant academic research and scientific papers

Synthesis of 2-methyl and ethyl-substituted 19-nor-1α,25- dihydroxyvitamin D3 analogues via the cyclovitamin strategy

The synthesis of several 19-nor-2-alkyl-1α,25-dihydroxyvitamin D 3 analogues (5-14) is described following the cyclovitamin strategy. Starting from all-cis methyl 3,5-dihydroxy-4-alkyl-1-cyclohexanecarboxylate (29), the eight stereoisomeric A-r